Clinical predictors of COVID-19 severity and bleeding in the ACTIV-4B COVID-19 outpatient thrombosis prevention trial.

Connors, Jean M; Brooks, Maria M; Sciurba, Frank C; Fu, Zhuxuan; Ridker, Paul M

Connors, Jean M; Brooks, Maria M; Sciurba, Frank C; Fu, Zhuxuan; Ridker, Paul M.

Connors JM; Hematology Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Brooks MM; Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Sciurba FC; Pulmonary Division, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Fu Z; Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Ridker PM; Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Am J Hematol ; 97(7): E235-E240, 2022 07.

Article in English | MEDLINE | ID: covidwho-1767300

Subject(s)

COVID-19; Thrombosis; Anticoagulants; COVID-19/complications; Clinical Trials as Topic; Hemorrhage/etiology; Hemorrhage/prevention & control; Humans; Outpatients; Thrombosis/etiology; Thrombosis/prevention & control

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombosis / COVID-19 Type of study: Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: Am J Hematol Year: 2022 Document Type: Article Affiliation country: Ajh.26553

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google